Ejaculatory Disorders

Part of the Contemporary Endocrinology book series (COE)


Ejaculation is a highly integrated process that involves both the sympathetic and parasympathetic neural pathways. Numerous studies reveal that ejaculatory dysfunction is a common disorder and the source of significant bother for many of those affected. Ejaculatory dysfunction comprises several different, more specific abnormalities including: premature ejaculation, inhibited ejaculation (consisting of delayed and absent ejaculation), and painful ejaculation. The evaluation of affected patients should include a comprehensive medical history, physical examination, and laboratory testing. Numerous therapeutic options are available to treat ejaculatory disorders, with many of these leading to marked improvement in patients’ symptoms and associated bother.


Desire Arousal Orgasm Resolution Emission Expulsion Premature ejaculation Inhibited ejaculation Delayed ejaculation Painful ejaculation Anejaculation 


  1. 1.
    Masters WH, Johnson VE. Human sexual response. Little, Brown and Company: Boston, MA; 1966.Google Scholar
  2. 2.
    Rosen R, Altwein J, Boyle P, Kirby RS, Lukacs B, Meuleman E, et al. Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7). Eur Urol. 2003;44(6):637–49.PubMedCrossRefGoogle Scholar
  3. 3.
    Giuliano F, Clement P. Physiology of ejaculation: emphasis on serotonergic control. Eur Urol. 2005;48(3):408–17.PubMedCrossRefGoogle Scholar
  4. 4.
    Newman HF, Reiss H, Northup JD. Physical basis of emission, ejaculation, and orgasm in the male. Urology. 1982;19(4):341–50.PubMedCrossRefGoogle Scholar
  5. 5.
    Barnas JL, Pierpaoli S, Ladd P, Valenzuela R, Aviv N, Parker M, et al. The prevalence and nature of orgasmic dysfunction after radical prostatectomy. BJU Int. 2004;94(4):603–5.PubMedCrossRefGoogle Scholar
  6. 6.
    Schlegel PN, Walsh PC. Neuroanatomical approach to radical cystoprostatectomy with preservation of sexual function. J Urol. 1987;138(6):1402–6.PubMedGoogle Scholar
  7. 7.
    Keast J. Autonomic Ganglia. In: McLachlan E, editor. Pelvic ganglia. Luxemburg: Harwood Academin; 1995. p. 445–79.Google Scholar
  8. 8.
    Ver Voort SM. Ejaculatory stimulation in spinal-cord injured men. Urology. 1987;29(3):282–9.PubMedCrossRefGoogle Scholar
  9. 9.
    Amelar RD, Hotchkiss RS. The split ejaculate: its use in the management of male infertility. Fertil Steril. 1965;16:46–60.PubMedCrossRefGoogle Scholar
  10. 10.
    McKenna KE, Chung SK, McVary KT. A model for the study of sexual function in anesthetized male and female rats. Am J Physiol. 1991;261(5 Pt 2):R1276–85.PubMedGoogle Scholar
  11. 11.
    Truitt WA, Coolen LM. Identification of a potential ejaculation generator in the spinal cord. Science. 2002;297(5586):1566–9.PubMedCrossRefGoogle Scholar
  12. 12.
    Allard J, Truitt WA, McKenna KE, Coolen LM. Spinal cord control of ejaculation. World J Urol. 2005;23(2):119–26.PubMedCrossRefGoogle Scholar
  13. 13.
    Coolen LM, Allard J, Truitt WA, McKenna KE. Central regulation of ejaculation. Physiol Behav. 2004;83(2):203–15.PubMedCrossRefGoogle Scholar
  14. 14.
    Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. JAMA. 1999;281(6):537–44.PubMedCrossRefGoogle Scholar
  15. 15.
    Dunn KM, Croft PR, Hackett GI. Association of sexual problems with social, psychological, and physical problems in men and women: a cross sectional population survey. J Epidemiol Community Health. 1999;53(3):144–8.PubMedPubMedCentralCrossRefGoogle Scholar
  16. 16.
    Masters WH, Johnson VE. Human sexual inadequacy. London: Churchill; 1970. p. xi–467.Google Scholar
  17. 17.
    Waldinger MD, Schweitzer DH. Changing paradigms from a historical DSM-III and DSM-IV view toward an evidence-based definition of premature ejaculation. Part I – validity of DSM-IV-TR. J Sex Med. 2006;3(4):682–92.PubMedCrossRefGoogle Scholar
  18. 18.
    Symonds T, Perelman M, Althof S, Giuliano F, Martin M, Abraham L, et al. Further evidence of the reliability and validity of the premature ejaculation diagnostic tool. Int J Impot Res. 2007;19(5):521–5.PubMedCrossRefGoogle Scholar
  19. 19.
    Waldinger MD, Hengeveld MW, Zwinderman AH. Paroxetine treatment of premature ejaculation: a double-blind, randomized, placebo-controlled study. Am J Psychiatry. 1994;151(9):1377–9.PubMedCrossRefGoogle Scholar
  20. 20.
    Patrick DL, Althof SE, Pryor JL, Rosen R, Rowland DL, Ho KF, et al. Premature ejaculation: an observational study of men and their partners. J Sex Med. 2005;2(3):358–67.PubMedCrossRefGoogle Scholar
  21. 21.
    Rowland DL, Cooper SE, Schneider M. Defining premature ejaculation for experimental and clinical investigations. Arch Sex Behav. 2001;30(3):235–53.PubMedCrossRefGoogle Scholar
  22. 22.
    Waldinger MD, Zwinderman AH, Olivier B, Schweitzer DH. Proposal for a definition of lifelong premature ejaculation based on epidemiological stopwatch data. J Sex Med. 2005;2(4):498–507.PubMedCrossRefGoogle Scholar
  23. 23.
    Dinsmore WW, Ralph DJ, Kell P, Wylie KR, Dean JP, Novak C, et al. Evaluation of the sexual assessment monitor, a diagnostic device used to electronically quantify ejaculatory latency time: findings from three studies. BJU Int. 2006;98(3):613–8.PubMedCrossRefGoogle Scholar
  24. 24.
    Lue TF, Giuliano F, Montorsi F, Rosen RC, Andersson KE, Althof S, et al. Summary of the recommendations on sexual dysfunctions in men. J Sex Med. 2004;1(1):6–23.PubMedCrossRefGoogle Scholar
  25. 25.
    Sharlip ID. Guidelines for the diagnosis and management of premature ejaculation. J Sex Med. 2006;3 Suppl 4:309–17.PubMedCrossRefGoogle Scholar
  26. 26.
    Montague DK, Jarow J, Broderick GA, Dmochowski RR, Heaton JP, Lue TF, et al. AUA guideline on the pharmacologic management of premature ejaculation. J Urol. 2004;172(1):290–4.PubMedCrossRefGoogle Scholar
  27. 27.
    Colpi GM, Fanciullacci F, Beretta G, Negri L, Zanollo A. Evoked sacral potentials in subjects with true premature ejaculation. Andrologia. 1986;18(6):583–6.CrossRefPubMedGoogle Scholar
  28. 28.
    Fanciullacci F, Colpi GM, Beretta G, Zanollo A. Cortical evoked potentials in subjects with true premature ejaculation. Andrologia. 1988;20(4):326–30.PubMedCrossRefGoogle Scholar
  29. 29.
    Shull GR, Sprenkle DH. Retarded ejaculation reconceptualization and implications for treatment. J Sex Marital Ther. 1980;6(4):234–46.PubMedCrossRefGoogle Scholar
  30. 30.
    Semans JH. Premature ejaculation: a new approach. South Med J. 1956;49(4):353–8.PubMedCrossRefGoogle Scholar
  31. 31.
    De Amicis LA, Goldberg DC, LoPiccolo J, Friedman J, Davies L. Clinical follow-up of couples treated for sexual dysfunction. Arch Sex Behav. 1985;14(6):467–89.PubMedCrossRefGoogle Scholar
  32. 32.
    Busato W, Galindo CC. Topical anaesthetic use for treating premature ejaculation: a double-blind, randomized, placebo-controlled study. BJU Int. 2004;93(7):1018–21.PubMedCrossRefGoogle Scholar
  33. 33.
    Henry R, Morales A. Topical lidocaine-prilocaine spray for the treatment of premature ejaculation: a proof of concept study. Int J Impot Res. 2003;15(4):277–81.PubMedCrossRefGoogle Scholar
  34. 34.
    Hull EM, Lumley LA, Matuszewich L, Dominguez J, Moses J, Lorrain DS. The roles of nitric oxide in sexual function of male rats. Neuropharmacology. 1994;33(11):1499–504.PubMedCrossRefGoogle Scholar
  35. 35.
    McMahon CG, Stuckey BG, Andersen M, Purvis K, Koppiker N, Haughie S, et al. Efficacy of sildenafil citrate (Viagra) in men with premature ejaculation. J Sex Med. 2005;2(3):368–75.PubMedCrossRefGoogle Scholar
  36. 36.
    Pryor JL, Althof SE, Steidle C, Rosen RC, Hellstrom WJ, Shabsigh R, et al. Efficacy and tolerability of dapoxetine in treatment of premature ejaculation: an integrated analysis of two double-blind, randomised controlled trials. Lancet. 2006;368(9539):929–37.PubMedCrossRefGoogle Scholar
  37. 37.
    Safarinejad MR. Safety and efficacy of dapoxetine in the treatment of premature ejaculation: a double-blind, placebo-controlled, fixed-dose, randomized study. Neuropsychopharmacology. 2008;33(6):1259–65.PubMedCrossRefGoogle Scholar
  38. 38.
    Waldinger MD, Schweitzer DH. Premature ejaculation and pharmaceutical company-based medicine: the dapoxetine case. J Sex Med. 2008;5(4):966–97.PubMedCrossRefGoogle Scholar
  39. 39.
    Kim JJ, Kwak TI, Jeon BG, Cheon J, Moon DG. Effects of glans penis augmentation using hyaluronic acid gel for premature ejaculation. Int J Impot Res. 2004;16(6):547–51.CrossRefPubMedGoogle Scholar
  40. 40.
    Lue TF, Basson R, Rosen R, Giuliano F, Khoury S, Montorsi F. Sexual medicine: sexual dysfunctions in men and women. In: McMahon CG, Abdo C, Hull EM, Incrocci L, Levine L, Perelman MA, et al., editors. Plymouth, MA: Health Publications; 2004. p. 409–68.Google Scholar
  41. 41.
    American Psychiatric Association. Diagnostic criteria from DSM-IV-TR. Washington, DC: American Psychiatric Association; 2000. p. 370, xii.Google Scholar
  42. 42.
    McMahon CG, Jannini E, Waldinger M, Rowland D. Standard operating procedures in the disorders of orgasm and ejaculation. J Sex Med. 2013;10(1):204–29.PubMedCrossRefGoogle Scholar
  43. 43.
    Kinsey AC, Pomeroy WB, Martin CE, New York Academy of Medicine. Sexual behavior in the human male. Philadelphia, PA: WB Saunders Co; 1948. p. 804, xv.Google Scholar
  44. 44.
    Rowland DL, Keeney C, Slob AK. Sexual response in men with inhibited or retarded ejaculation. Int J Impot Res. 2004;16(3):270–4.PubMedCrossRefGoogle Scholar
  45. 45.
    Nathan SG. The epidemiology of the DSM-III psychosexual dysfunctions. J Sex Marital Ther. 1986;12(4):267–81.PubMedCrossRefGoogle Scholar
  46. 46.
    Richardson D, Nalabanda A, Goldmeier D. Retarded ejaculation – a review. Int J STD AIDS. 2006;17(3):143–50.PubMedCrossRefGoogle Scholar
  47. 47.
    Spector IP, Carey MP. Incidence and prevalence of the sexual dysfunctions: a critical review of the empirical literature. Arch Sex Behav. 1990;19(4):389–408.PubMedCrossRefGoogle Scholar
  48. 48.
    Nazareth I, Boynton P, King M. Problems with sexual function in people attending London general practitioners: cross sectional study. BMJ. 2003;327(7412):423.PubMedPubMedCentralCrossRefGoogle Scholar
  49. 49.
    McCabe MP, Connaughton C. Psychosocial factors associated with male sexual difficulties. J Sex Res. 2014;51(1):31–42.PubMedCrossRefGoogle Scholar
  50. 50.
    Mulhall JP, Hsiao W. Men’s sexual health and fertility: a clinician’s guide. Nelson CJ, Brock D, Dean RC, editors. New York, NY: Springer; 2014.CrossRefGoogle Scholar
  51. 51.
    Jannini EA, Simonelli C, Lenzi A. Sexological approach to ejaculatory dysfunction. Int J Androl. 2002;25(6):317–23.PubMedCrossRefGoogle Scholar
  52. 52.
    Jannini EA, Simonelli C, Lenzi A. Disorders of ejaculation. J Endocrinol Invest. 2002;25(11):1006–19.PubMedCrossRefGoogle Scholar
  53. 53.
    Montorsi F, Adaikan G, Becher E, Giuliano F, Khoury S, Lue TF, et al. Summary of the recommendations on sexual dysfunctions in men. J Sex Med. 2010;7(11):3572–88.PubMedCrossRefGoogle Scholar
  54. 54.
    Abdel-Hamid IA, el Saleh S. Primary lifelong delayed ejaculation: characteristics and response to bupropion. J Sex Med. 2011;8(6):1772–9.PubMedCrossRefGoogle Scholar
  55. 55.
    Perelman MA, Rowland DL. Retarded ejaculation. World J Urol. 2006;24(6):645–52.PubMedCrossRefGoogle Scholar
  56. 56.
    Perelman MA. Delayed ejaculation. In: Binik YM, Hall KSK, editors. Principles and practice of sex therapy. 5th ed. New York, NY: The Guilford Press; 2014. p. 138–55.Google Scholar
  57. 57.
    Waldinger MD. Toward evidence-based genetic research on lifelong premature ejaculation: a critical evaluation of methodology. Korean J Urol. 2011;52(1):1–8.PubMedPubMedCentralCrossRefGoogle Scholar
  58. 58.
    Gregoire A. ABC of sexual health: assessing and managing male sexual problems. BMJ. 1999;318(7179):315–7.PubMedPubMedCentralCrossRefGoogle Scholar
  59. 59.
    McMahon CG, Abdo C, Incrocci L, Perelman M, Rowland D, Waldinger M, et al. Disorders of orgasm and ejaculation in men. J Sex Med. 2004;1(1):58–65.PubMedCrossRefGoogle Scholar
  60. 60.
    Edwards AE, Husted JR. Penile sensitivity, age, and sexual behavior. J Clin Psychol. 1976;32(3):697–700.PubMedCrossRefGoogle Scholar
  61. 61.
    Waldinger MD, Quinn P, Dilleen M, Mundayat R, Schweitzer DH, Boolell M. A multinational population survey of intravaginal ejaculation latency time. J Sex Med. 2005;2(4):492–7.PubMedCrossRefGoogle Scholar
  62. 62.
    Latini DM, Penson DF, Wallace KL, Lubeck DP, Lue TF. Clinical and psychosocial characteristics of men with erectile dysfunction: baseline data from ExCEED. J Sex Med. 2006;3(6):1059–67.PubMedCrossRefGoogle Scholar
  63. 63.
    Gierveld Jde J, van Groenou MB, Hoogendoorn AW, Smit JH. Quality of marriages in later life and emotional and social loneliness. J Gerontol B Psychol Sci Soc Sci. 2009;64(4):497–506.PubMedCrossRefGoogle Scholar
  64. 64.
    DasGupta R, Fowler CJ. Sexual and urological dysfunction in multiple sclerosis: better understanding and improved therapies. Curr Opin Neurol. 2002;15(3):271–8.PubMedCrossRefGoogle Scholar
  65. 65.
    Enzlin P, Mathieu C, Van Den Bruel A, Vanderschueren D, Demyttenaere K. Prevalence and predictors of sexual dysfunction in patients with type 1 diabetes. Diabetes Care. 2003;26(2):409–14.PubMedCrossRefGoogle Scholar
  66. 66.
    Minderhoud JM, Leemhuis JG, Kremer J, Laban E, Smits PM. Sexual disturbances arising from multiple sclerosis. Acta Neurol Scand. 1984;70(4):299–306.PubMedCrossRefGoogle Scholar
  67. 67.
    Comarr AE. Sexual function among patients with spinal cord injury. Urol Int. 1970;25(2):134–68.PubMedCrossRefGoogle Scholar
  68. 68.
    Xia JD, Han YF, Pan F, Zhou LH, Chen Y, Dai YT. Clinical characteristics and penile afferent neuronal function in patients with primary delayed ejaculation. Andrology. 2013;1(5):787–92.PubMedCrossRefGoogle Scholar
  69. 69.
    Fletcher MS, Herzberg Z, Pryor JP. The aetiology and investigation of haemospermia. Br J Urol. 1981;53(6):669–71.PubMedCrossRefGoogle Scholar
  70. 70.
    Corona G, Jannini EA, Mannucci E, Fisher AD, Lotti F, Petrone L, et al. Different testosterone levels are associated with ejaculatory dysfunction. J Sex Med. 2008;5(8):1991–8.PubMedCrossRefGoogle Scholar
  71. 71.
    Corona G, Jannini EA, Vignozzi L, Rastrelli G, Maggi M. The hormonal control of ejaculation. Nat Rev Urol. 2012;9(9):508–19.PubMedCrossRefGoogle Scholar
  72. 72.
    Paduch D, Polzer P, Ni X, Basaria S. Effects of testosterone solution 2 % for the treatment of ejauclatory dysfunction in androgen-deficient men. 20th Annual fall scientific meeting of SMSNA, 20–23 Nov 2014 Program Book. 2014(Abtract 003):53.Google Scholar
  73. 73.
    Paduch D, Polzer P, Morgentaler A, Althof SE, Ni X, Patel A, et al. Prevalence of ejaculatory dysfunction as a function of testosterone. 20th Annual fall scientific meeting of SMSNA, 20–23 Nov 2014 Program Book. 2014(Abstract 004):52.Google Scholar
  74. 74.
    Paduch D, Polzer P, Ni X, Basaria S. Testosterone replacement in androgen-deficient men with ejaculatory dysfunction: a randomized controlled trial. J Clin Endocrinol Metab. 2015;100(8):2956–62.PubMedCrossRefGoogle Scholar
  75. 75.
    Carani C, Isidori AM, Granata A, Carosa E, Maggi M, Lenzi A, et al. Multicenter study on the prevalence of sexual symptoms in male hypo- and hyperthyroid patients. J Clin Endocrinol Metab. 2005;90(12):6472–9.PubMedCrossRefGoogle Scholar
  76. 76.
    Corona G, Petrone L, Paggi F, Lotti F, Boddi V, Fisher A, et al. Sexual dysfunction in subjects with Klinefelter’s syndrome. Int J Androl. 2010;33(4):574–80.PubMedGoogle Scholar
  77. 77.
    Fitzgerald P, Dinan TG. Prolactin and dopamine: what is the connection? A review article. J Psychopharmacol. 2008;22(2 Suppl):12–9.PubMedCrossRefGoogle Scholar
  78. 78.
    Kruger TH, Hartmann U, Schedlowski M. Prolactinergic and dopaminergic mechanisms underlying sexual arousal and orgasm in humans. World J Urol. 2005;23(2):130–8.PubMedCrossRefGoogle Scholar
  79. 79.
    Corona G, Ricca V, Bandini E, Mannucci E, Lotti F, Boddi V, et al. Selective serotonin reuptake inhibitor-induced sexual dysfunction. J Sex Med. 2009;6(5):1259–69.PubMedCrossRefGoogle Scholar
  80. 80.
    Kiev A, Feiger A. A double-blind comparison of fluvoxamine and paroxetine in the treatment of depressed outpatients. J Clin Psychiatry. 1997;58(4):146–52.PubMedCrossRefGoogle Scholar
  81. 81.
    Keller R, Mongini F. Switch to quetiapine in antipsychotic agent-related hyperprolactinemia. Neurol Sci. 2002;23(5):233–5.PubMedCrossRefGoogle Scholar
  82. 82.
    Rowland D, van Diest S, Incrocci L, Slob AK. Psychosexual factors that differentiate men with inhibited ejaculation from men with no dysfunction or another sexual dysfunction. J Sex Med. 2005;2(3):383–9.PubMedCrossRefGoogle Scholar
  83. 83.
    Althof SE. Psychological interventions for delayed ejaculation/orgasm. Int J Impot Res. 2012;24(4):131–6.PubMedCrossRefGoogle Scholar
  84. 84.
    Fathy A, Shamloul R, AbdelRahim A, Zeidan A, El-Dakhly R, Ghanem H. Experience with Tube (Promedon) malleable penile implant. Urol Int. 2007;79(3):244–7.PubMedCrossRefGoogle Scholar
  85. 85.
    Shaeer O. The global online sexuality survey (GOSS): the United States of America in 2011 Chapter III – premature ejaculation among English-speaking male Internet users. J Sex Med. 2013;10(7):1882–8.PubMedCrossRefGoogle Scholar
  86. 86.
    Bronner G, Ben-Zion IZ. Unusual masturbatory practice as an etiological factor in the diagnosis and treatment of sexual dysfunction in young men. J Sex Med. 2014;11(7):1798–806.PubMedCrossRefGoogle Scholar
  87. 87.
    Perelman M. Idiosyncratic masturbation patterns: a key unexplored variable in the treatment of retarded ejaculation by the practicing urologist. J Urol. 2005;173:340. Abstract 1254.CrossRefGoogle Scholar
  88. 88.
    Sank LI. Traumatic masturbatory syndrome. J Sex Marital Ther. 1998;24(1):37–42.PubMedCrossRefGoogle Scholar
  89. 89.
    Rothbart D. He’s just not that into anyone (cover story). New York, 2 Jul 2011, p. 83–8.Google Scholar
  90. 90.
    Carvalheira A, Traeen B, Stulhofer A. Masturbation and pornography use among coupled heterosexual men with decreased sexual desire: how many roles of masturbation? J Sex Marital Ther. 2014;1–10.Google Scholar
  91. 91.
    Rowland D, McMahon CG, Abdo C, Chen J, Jannini E, Waldinger MD, et al. Disorders of orgasm and ejaculation in men. J Sex Med. 2010;7(4 Pt 2):1668–86.PubMedCrossRefGoogle Scholar
  92. 92.
    Teloken P, Nelson C, Mullhall J. Outcomes with medical treatment of secondary delayed orgasm proposal of a clinical care pathway. J Urol. 2012;187(4 Suppl 1496):606.CrossRefGoogle Scholar
  93. 93.
    Butcher M, Sadowski D, Botchway A, Welliver C, Kohler T. Delayed ejaculation remains a recalcitrant condition: results of a SMSNA survey. 20th Annual fall scientific meeting of SMSNA, 20–23 Nov 2014. Program Book. 2014(Abstract 041):70.Google Scholar
  94. 94.
    Porst H, Buvat J, Standards Committee of the International Society for Sexual Medicine. Standard practice in sexual medicine. McMahon CG, Waldinger M, Rowland D, Assalian P, Kim YC, Bechara A, et al., editors. Malden, Mass.; Oxford: Blackwell Pub. 2006. p. 188–209.Google Scholar
  95. 95.
    Aukst-Margetic B, Margetic B. An open-label series using loratadine for the treatment of sexual dysfunction associated with selective serotonin reuptake inhibitors. Prog Neuropsychopharmacol Biol Psychiatry. 2005;29(5):754–6.PubMedCrossRefGoogle Scholar
  96. 96.
    Shin D, Spitz A. The evaluation and treatment of delayed ejaculation. Sex Med Rev. 2014;2(3-4):121–33.CrossRefGoogle Scholar
  97. 97.
    Menendez Abraham E, Moran Viesca P, Velasco Plaza A, Marin B. Modifications of the sexual activity in male rats following administration of antiserotoninergic drugs. Behav Brain Res. 1988;30(3):251–8.PubMedCrossRefGoogle Scholar
  98. 98.
    Ashton AK, Hamer R, Rosen RC. Serotonin reuptake inhibitor-induced sexual dysfunction and its treatment: a large-scale retrospective study of 596 psychiatric outpatients. J Sex Marital Ther. 1997;23(3):165–75.CrossRefGoogle Scholar
  99. 99.
    Lauerma H. Successful treatment of citalopram-induced anorgasmia by cyproheptadine. Acta Psychiatr Scand. 1996;93(1):69–70.PubMedCrossRefGoogle Scholar
  100. 100.
    Steele TE, Howell EF. Cyproheptadine for imipramine-induced anorgasmia. J Clin Psychopharmacol. 1986;6(5):326–7.PubMedCrossRefGoogle Scholar
  101. 101.
    Sovner R. Treatment of tricyclic antidepressant-induced orgasmic inhibition with cyproheptadine. J Clin Psychopharmacol. 1984;4(3):169.PubMedCrossRefGoogle Scholar
  102. 102.
    McCormick S, Olin J, Brotman AW. Reversal of fluoxetine-induced anorgasmia by cyproheptadine in two patients. J Clin Psychiatry. 1990;51(9):383–4.PubMedGoogle Scholar
  103. 103.
    DeBattista C, Solvason B, Poirier J, Kendrick E, Loraas E. A placebo-controlled, randomized, double-blind study of adjunctive bupropion sustained release in the treatment of SSRI-induced sexual dysfunction. J Clin Psychiatry. 2005;66(7):844–8.PubMedCrossRefGoogle Scholar
  104. 104.
    Safarinejad MR. Midodrine for the treatment of organic anejaculation but not spinal cord injury: a prospective randomized placebo-controlled double-blind clinical study. Int J Impot Res. 2009;21(4):213–20.PubMedCrossRefGoogle Scholar
  105. 105.
    Ferraz MM, Fontanella JC, Damasceno F, Silva de Almeida OM, Ferraz MR. Chronic amantadine treatment enhances the sexual behaviour of male rats. Pharmacol Biochem Behav. 2007;86(4):616–21.PubMedCrossRefGoogle Scholar
  106. 106.
    Balon R. Intermittent amantadine for fluoxetine-induced anorgasmia. J Sex Marital Ther. 1996;22(4):290–2.PubMedCrossRefGoogle Scholar
  107. 107.
    Wittstock M, Benecke R, Dressler D. Cabergoline can increase penile erections and libido. Neurology. 2002;58(5):831.CrossRefPubMedGoogle Scholar
  108. 108.
    Kruger TH, Haake P, Haverkamp J, Kramer M, Exton MS, Saller B, et al. Effects of acute prolactin manipulation on sexual drive and function in males. J Endocrinol. 2003;179(3):357–65.PubMedCrossRefGoogle Scholar
  109. 109.
    Veening JG, de Jong TR, Waldinger MD, Korte SM, Olivier B. The role of oxytocin in male and female reproductive behavior. Eur J Pharmacol. 2015;753:209–28.PubMedCrossRefGoogle Scholar
  110. 110.
    Labbate LA, Grimes JB, Hines A, Pollack MH. Bupropion treatment of serotonin reuptake antidepressant-associated sexual dysfunction. Ann Clin Psychiatry. 1997;9(4):241–5.PubMedCrossRefGoogle Scholar
  111. 111.
    Ashton AK, Rosen RC. Bupropion as an antidote for serotonin reuptake inhibitor-induced sexual dysfunction. J Clin Psychiatry. 1998;59(3):112–5.PubMedCrossRefGoogle Scholar
  112. 112.
    Landen M, Eriksson E, Agren H, Fahlen T. Effect of buspirone on sexual dysfunction in depressed patients treated with selective serotonin reuptake inhibitors. J Clin Psychopharmacol. 1999;19(3):268–71.PubMedCrossRefGoogle Scholar
  113. 113.
    Carro-Juareza M, Rodriguez-Manzo G. Yohimbine reverses the exhaustion of the coital reflex in spinal male rats. Behav Brain Res. 2003;141(1):43–50.PubMedCrossRefGoogle Scholar
  114. 114.
    Jacobsen FM. Fluoxetine-induced sexual dysfunction and an open trial of yohimbine. J Clin Psychiatry. 1992;53(4):119–22.PubMedGoogle Scholar
  115. 115.
    Adeniyi AA, Brindley GS, Pryor JP, Ralph DJ. Yohimbine in the treatment of orgasmic dysfunction. Asian J Androl. 2007;9(3):403–7.PubMedCrossRefGoogle Scholar
  116. 116.
    Melnyk J, Marcone M. Aphrodisiacs from plant and animal sources—a review of current scientific literature. Food Res Int. 2011;44:840–50.CrossRefGoogle Scholar
  117. 117.
    Segraves RT. Reversal by bethanechol of imipramine-induced ejaculatory dysfunction. Am J Psychiatry. 1987;144(9):1243–4.PubMedGoogle Scholar
  118. 118.
    Yager J. Bethanechol chloride can reverse erectile and ejaculatory dysfunction induced by tricyclic antidepressants and mazindol: case report. J Clin Psychiatry. 1986;47(4):210–1.PubMedGoogle Scholar
  119. 119.
    Stafford SA, Coote JH. Activation of D2-like receptors induces sympathetic climactic-like responses in male and female anaesthetised rats. Br J Pharmacol. 2006;148(4):510–6.PubMedPubMedCentralCrossRefGoogle Scholar
  120. 120.
    Lu W, Jiang W, Chen J, Yin M, Wang Z, Jiang X. Modulation of brain delivery and copulation by intranasal apomorphine hydrochloride. Int J Pharm. 2008;349(1-2):196–205.PubMedCrossRefGoogle Scholar
  121. 121.
    Kendirci M, Hellstrom WJ. Intranasal apomorphine. Nastech Pharmaceutical. Investig Drug J. 2004;7(5):483–8.Google Scholar
  122. 122.
    Bartlik BD, Kaplan P, Kaplan HS. Psychostimulants apparently reverse sexual dysfunction secondary to selective serotonin re-uptake inhibitors. J Sex Marital Ther. 1995;21(4):264–71.PubMedCrossRefGoogle Scholar
  123. 123.
    McMahon CG. Management of ejaculatory dysfunction. Intern Med J. 2014;44(2):124–31.PubMedCrossRefGoogle Scholar
  124. 124.
    Haberfellner EM. Sexual dysfunction caused by reboxetine. Pharmacopsychiatry. 2002;35(2):77–8.PubMedCrossRefGoogle Scholar
  125. 125.
    O'Flynn R, Michael A. Reboxetine-induced spontaneous ejaculation. Br J Psychiatry. 2000;177:567–8.PubMedCrossRefGoogle Scholar
  126. 126.
    Sivrioglu EY, Topaloglu VC, Sarandol A, Akkaya C, Eker SS, Kirli S. Reboxetine induced erectile dysfunction and spontaneous ejaculation during defecation and micturition. Prog Neuropsychopharmacol Biol Psychiatry. 2007;31(2):548–50.PubMedCrossRefGoogle Scholar
  127. 127.
    Taylor MJ. Strategies for managing antidepressant-induced sexual dysfunction: a review. Curr Psychiatry Rep. 2006;8(6):431–6.PubMedCrossRefGoogle Scholar
  128. 128.
    Schweitzer I, Maguire K, Ng C. Sexual side-effects of contemporary antidepressants: review. Aust N Z J Psychiatry. 2009;43(9):795–808.PubMedCrossRefGoogle Scholar
  129. 129.
    Sonksen J, Ohl DA, Wedemeyer G. Sphincteric events during penile vibratory ejaculation and electroejaculation in men with spinal cord injuries. J Urol. 2001;165(2):426–9.PubMedCrossRefGoogle Scholar
  130. 130.
    Nelson CJ, Ahmed A, Valenzuela R, Parker M, Mulhall JP. Assessment of penile vibratory stimulation as a management strategy in men with secondary retarded orgasm. Urology. 2007;69(3):552–5. discussion 5–6.PubMedPubMedCentralCrossRefGoogle Scholar
  131. 131.
    Previnaire JG, Lecourt G, Soler JM, Denys P. Sexual disorders in men with multiple sclerosis: evaluation and management. Ann Phys Rehabil Med. 2014;57(5):329–36.PubMedCrossRefGoogle Scholar
  132. 132.
    Lieblum S, Rosen R. Principles and practice of sex therapy. 2nd ed. New York, NY: Guilford Press; 2000.Google Scholar
  133. 133.
    Perelman MA. A new combination treatment for premature ejaculation: a sex therapist's perspective. J Sex Med. 2006;3(6):1004–12.PubMedCrossRefGoogle Scholar
  134. 134.
    Rust J, Golombok S, Collier J. Marital problems and sexual dysfunction: how are they related? Br J Psychiatry. 1988;152:629–31.PubMedCrossRefGoogle Scholar
  135. 135.
    Snyder DK, Berg P. Determinants of sexual dissatisfaction in sexually distressed couples. Arch Sex Behav. 1983;12(3):237–46.PubMedCrossRefGoogle Scholar
  136. 136.
    Barnas J, Parker M, Guhring P, Mulhall JP. The utility of tamsulosin in the management of orgasm-associated pain: a pilot analysis. Eur Urol. 2005;47(3):361–5. discussion 5.PubMedCrossRefGoogle Scholar
  137. 137.
    Johnson CW, Bingham JB, Goluboff ET, Fisch H. Transurethral resection of the ejaculatory ducts for treating ejaculatory symptoms. BJU Int. 2005;95(1):117–9.PubMedCrossRefGoogle Scholar
  138. 138.
    Antolak S, Hough D, Maus T. Chronic pelvic pain syndrome (pudendal neuralgia or category IIIB chronic prostatitis). Rochester, MN: Mayo Clinic; 2002.Google Scholar
  139. 139.
    Kulik FA, Wilbur R. Case report of painful ejaculation as a side effect of amoxapine. Am J Psychiatry. 1982;139(2):234–5.PubMedCrossRefGoogle Scholar
  140. 140.
    Aizenberg D, Zemishlany Z, Hermesh H, Karp L, Weizman A. Painful ejaculation associated with antidepressants in four patients. J Clin Psychiatry. 1991;52(11):461–3.PubMedGoogle Scholar
  141. 141.
    Hsu JH, Shen WW. Male sexual side effects associated with antidepressants: a descriptive clinical study of 32 patients. Int J Psychiatry Med. 1995;25(2):191–201.PubMedCrossRefGoogle Scholar
  142. 142.
    Michael A. Venlafaxine-induced painful ejaculation. Br J Psychiatry. 2000;177:282.PubMedCrossRefGoogle Scholar
  143. 143.
    Demyttenaere K, Huygens R. Painful ejaculation and urinary hesitancy in association with antidepressant therapy: relief with tamsulosin. Eur Neuropsychopharmacol. 2002;12(4):337–41.PubMedCrossRefGoogle Scholar
  144. 144.
    Roberts RO, Jacobson DJ, Girman CJ, Rhodes T, Lieber MM, Jacobsen SJ. Prevalence of prostatitis-like symptoms in a community based cohort of older men. J Urol. 2002;168(6):2467–71.PubMedCrossRefGoogle Scholar
  145. 145.
    Nickel JC, Downey J, Hunter D, Clark J. Prevalence of prostatitis-like symptoms in a population based study using the National Institutes of Health chronic prostatitis symptom index. J Urol. 2001;165(3):842–5.PubMedCrossRefGoogle Scholar
  146. 146.
    Litwin MS, McNaughton-Collins M, Fowler Jr FJ, Nickel JC, Calhoun EA, Pontari MA, et al. The National Institutes of Health chronic prostatitis symptom index: development and validation of a new outcome measure. Chronic Prostatitis Collaborative Research Network. J Urol. 1999;162(2):369–75.PubMedCrossRefGoogle Scholar
  147. 147.
    Amarenco G, Ismael SS, Bayle B, Denys P, Kerdraon J. Electrophysiological analysis of pudendal neuropathy following traction. Muscle Nerve. 2001;24(1):116–9.PubMedCrossRefGoogle Scholar
  148. 148.
    Nadler RB, Rubenstein JN. Laparoscopic excision of a seminal vesicle for the chronic pelvic pain syndrome. J Urol. 2001;166(6):2293–4.PubMedCrossRefGoogle Scholar
  149. 149.
    Anderson RU, Wise D, Sawyer T, Chan CA. Sexual dysfunction in men with chronic prostatitis/chronic pelvic pain syndrome: improvement after trigger point release and paradoxical relaxation training. J Urol. 2006;176(4 Pt 1):1534–8. discussion 8–9.PubMedCrossRefGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2016

Authors and Affiliations

  1. 1.Department of Urology/Sexual MedicinePark Nicollet Health PartnersSaint Louis ParkUSA
  2. 2.Department of UrologyNorthwestern Memorial HospitalChicagoUSA

Personalised recommendations